Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Cellarity, Lifecore Biomedical, Microbot, SHL Medical, Vuze.

Additional early-stage research and drug discovery news in brief, from: Beyond Cancer, Biohaven, Corbus, Destiny, Myricx, Nextcure, Promontory, Storm, Venatorx.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Almirall, Alar Pharmaceuticals, Astellas Pharma, Biolabs Global, Biolinerx, Canariabio, Epimab Biotherapeutics, Gloria Biosciences , GC Biopharma, Glycotope, GPCR Therapeutics, Indivior, Immetas Therapeutics, Legochem, KPB Biosciences, Mitsui Fudosan, Novo Nordisk, Sosei Group, Specialised Therapeutics Asia, Taigen Biopharmaceuticals, Y.S.P. Industries.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aim, Bioaegis, Blue, Castlevax, Elevar, GRI, Immunos, Kyowa Kirin, Lumen, Lytix, Merck, Notable, Poolbeg, Revive, Sana, Seelos, Spark, Splicebio, VBL, Y-mabs.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aidoc, Aimil, Bayer, Cardio Diagnostics, Concertai, Evidation, Gleamer, Grail, Halo Precision Diagnostics, Odysight.ai, Oncotech, Optellum, Synerfuse, Terarecon.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Antiverse, Cimeio, Concentra,  Fortress, Globalbio, Glycotope, Helocyte, Hudson, KBP, Legochem, Lonza, Novo Nordisk, Rain, Shaperon, Sotio, Synaffix.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beyond Air.

Additional early-stage research and drug discovery news in brief, from: Galactica Pharmaceuticals, Strm Bio, Vedanta Biosciences.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Canariabio, Rational Vaccines, Specialised Therapeutics Asia, Theratechnologies.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allurion, Edwards, Glucotrack, Guerbet, Illumina, Inspiremd, Mindray, T2 Biosystems.